SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 152 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,375,000 | -3.5% | 125,000 | -16.7% | 1.56% | -2.5% |
| Q4 2017 | $2,460,000 | -59.0% | 150,000 | -62.5% | 1.60% | -3.1% |
| Q3 2017 | $6,000,000 | +217.1% | 400,000 | +86.0% | 1.65% | +54.6% |
| Q2 2017 | $1,892,000 | +142.6% | 215,000 | +43.3% | 1.07% | +177.2% |
| Q1 2017 | $780,000 | +7.7% | 150,000 | +20.0% | 0.39% | +30.8% |
| Q2 2016 | $724,000 | +59.5% | 125,000 | +66.7% | 0.30% | +77.7% |
| Q1 2016 | $454,000 | -75.1% | 75,000 | -62.5% | 0.17% | -72.4% |
| Q4 2015 | $1,826,000 | – | 200,000 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,400,000 | $12,320,000 | 4.56% |
| EcoR1 Capital, LLC | 2,568,119 | $22,599,000 | 4.01% |
| FIC CAPITAL INC | 960,338 | $8,451,000 | 3.48% |
| Opaleye Management Inc. | 580,000 | $5,104,000 | 2.13% |
| DAFNA Capital Management LLC | 225,000 | $1,980,000 | 1.41% |
| RA Capital Management | 1,250,000 | $11,000,000 | 1.26% |
| Iguana Healthcare Management, LLC | 215,000 | $1,892,000 | 1.07% |
| Avoro Capital Advisors LLC | 800,000 | $7,040,000 | 0.89% |
| WASATCH ADVISORS LP | 6,930,535 | $60,989,000 | 0.85% |
| Cormorant Asset Management, LP | 400,000 | $3,520,000 | 0.58% |